Vaccinia gangrenosa and 1-methylisatin 3-thiosemicarbazone (methisazone).
D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D005734:Gangrene / Q000209:etiology*; D006561:Herpes Simplex / Q000188:drug therapy; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D008875:Middle Aged; D012900:Smallpox Vaccine / Q000009:adverse effects*; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014615:Vaccinia / Q000188:drug therapy*
D000998:Antiviral Agents; D012900:Smallpox Vaccine; D013882:Thiosemicarbazones